Correlation of depth of gastric wall involvement and tumor response to HPE therapy. The number of cases of gastric pure (de novo) DLBCL and DLBCL(MALT) with available clinical staging (mucosa or submucosa invasion vs muscularlis, serosa, or perigastric lymph node involvement) in individual subgroups is indicated at the top of the corresponding histogram.